Preventing necrotizing enterocolitis by food additives in neonates

Medicine (United States)

Volumn 96, Issue 21, 2017, Pages

  Yu, Wentao ^a   Sui, Wu ^a   Mu, Linsong ^a   Yi, Wenying ^a   Li, Haijuan ^a   Wei, Liqin ^a   Yin, Weihong ^b  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

efficacy; food additives; necrotizing enterocolitis; network meta Analysis; premature infants

Indexed keywords

ARGININE; FOOD ADDITIVE; FRUCTOSE OLIGOSACCHARIDE; LACTOFERRIN; PENTOXIFYLLINE; PROBIOTIC AGENT;

COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL (TOPIC); EMBASE; HUMAN; INCIDENCE; MEDLINE; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN DISEASE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; DIET THERAPY; ENTEROCOLITIS, NECROTIZING; NETWORK META-ANALYSIS;

ENTEROCOLITIS, NECROTIZING; FOOD ADDITIVES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NETWORK META-ANALYSIS;

EID: 85020460329     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000006652     Document Type: Review

References (43)

1. Yang G, Wang Y, Jiang X. Diagnostic value of intestinal fatty-Acidbinding protein in necrotizing enterocolitis: A systematic review and meta-Analysis. Indian J Pediatr 2016;83:1410-9.
2. Yang Y, Guo Y, Kan Q, et al. A meta-Analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Braz JMed Biol Res 2014;47:804-10.
3. Hunter C, Dimaguila MA, Gal P, et al. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight
4. Rubin RT, Poland RE, Lesser IM, et al. Neuroendocrine aspects of primary endogenous depression. III. Cortisol secretion in relation to diagnosis and symptom patterns. Psychol Med 1987; 17:609-19.
5. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006;368:1271-83.
6. Lau CS, Chamberlain RS. Probiotic administration can prevent necrotizing enterocolitis in preterm infants: A meta-Analysis. J Pediatr Surg 2015;50:1405-12.
7. Bernardo WM, Aires FT, Carneiro RM, et al. Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: A systematic review and meta-Analysis. J Pediatr (Rio J) 2013;89:18-24.
8. Pammi M, Haque KN. Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 2015; CD004205.
9. Mitchell K, Lyttle A, Amin H, et al. Arginine supplementation in prevention of necrotizing enterocolitis in the premature infant: An updated systematic review. BMC Pediatr 2014;14:226.
10. Lawrence G, Tudehope D, Baumann K, et al. Enteral human IgG for prevention of necrotising enterocolitis: A placebo-controlled, randomised trial. Lancet 2001;357:2090-4.
11. Eibl MM, Wolf HM, Furnkranz H, et al. Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. N Engl J Med 1988;319:1-7.
12. Lauterbach R, Pawlik D, Kowalczyk D, et al. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: A placebo-controlled, double-blind trial. Crit Care Med 1999;27:807-14.
13. Amin HJ, Zamora SA, McMillan DD, et al. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 2002;140:425-31.
14. Dani C, Biadaioli R, Bertini G, et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82:103-8.
15. Costalos C, Skouteri V, Gounaris A, et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003;74:89-96.
16. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-6.
17. Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: A randomized study. Clin Infect Dis 2006;42:1735-42.
18. Rouge C, Piloquet H, Butel MJ, et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2009;89: 1828-35.
19. Samanta M, Sarkar M, Ghosh P, et al. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 2009;55:128-31.
20. Underwood MA, Salzman NH, Bennett SH, et al. A randomized placebocontrolled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal shortchain fatty acids. J Pediatr Gastroenterol Nutr 2009;48:216-25.
21. Adel M, Awad HA, Abdel-Naim AB, et al. Effects of pentoxifylline on coagulation profile and disseminated intravascular coagulation incidence in Egyptian septic neonates. J Clin Pharm Ther 2010;35:257-65.
22. Awad H, Mokhtar H, Imam SS, et al. Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. Pak J Biol Sci 2010;13:253-62.
23. Mihatsch WA, Vossbeck S, Eikmanns B, et al. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: A randomized controlled trial. Neonatology 2010;98:156-63.
24. Braga TD, da Silva GA, de Lira PI, et al. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: A double-blind, randomized, controlled trial. Am J Clin Nutr 2011;93:81-6.
25. Sari FN, Dizdar EA, Oguz S, et al. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: A randomized, controlled trial. Eur J Clin Nutr 2011;65:434-9.
26. Al-Hosni M, Duenas M, Hawk M, et al. Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol 2012;32: 253-9.
27. Fernandez-Carrocera LA, Solis-Herrera A, Cabanillas-Ayon M, et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2013;98:F5-9.
28. Polycarpou E, Zachaki S, Tsolia M, et al. Enteral L-Arginine supplementation for prevention of necrotizing enterocolitis in very low birth weight neonates: A double-blind randomized pilot study of efficacy and safety. JPEN J Parenter Enteral Nutr 2013;37:617-22.
29. Serce O, Benzer D, Gursoy T, et al. Efficacy of Saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: A randomised controlled trial. Early Hum Dev 2013;89:1033-6.
30. Akdag A, Dilmen U, Haque K, et al. Role of pentoxifylline and/or IgMenriched intravenous immunoglobulin in the management of neonatal sepsis. Am J Perinatol 2014;31:905-12.
31. Akin IM, Atasay B, Dogu F, et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. Am J Perinatol 2014;31:1111-20.
32. Benor S, Marom R, Ben Tov A, et al. Probiotic supplementation in mothers of very low birth weight infants. Am J Perinatol 2014;31: 497-504.
33. Manzoni P, Meyer M, Stolfi I, et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: A randomized clinical trial. Early Hum Dev 2014;90(suppl 1): S60-5.
34. Oncel MY, Sari FN, Arayici S, et al. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: A randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2014;99: F110-5.
35. Patole S, Keil AD, Chang A, et al. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates-A randomised double blind placebo controlled trial. PLoS One 2014;9: e89511.
36. Totsu S, Yamasaki C, Terahara M, et al. Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial. Pediatr Int 2014;56: 714-9.
37. Shabaan AE, Nasef N, Shouman B, et al. Pentoxifylline therapy for lateonset sepsis in preterm infants: A randomized controlled trial. Pediatr Infect Dis J 2015;34:e143-8.
38. Sherman MP, Adamkin DH, Niklas V, et al. Randomized controlled trial of talactoferrin oral solution in preterm infants. J Pediatr 2016;175: 68-73.e3.
39. Torrazza RM, Li N, Neu J. Decoding the enigma of necrotizing enterocolitis in premature infants. Pathophysiology 2014;21:21-7.
40. Fitzgibbons SC, Ching Y, Yu D, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 2009;44:1072-5; discussion 1075-76.
41. Payne D, Kubes P. Nitric oxide donors reduce the rise in reperfusioninduced intestinal mucosal permeability. Am J Physiol 1993;265: G189-95.
42. Caplan MS, Hedlund E, Hill N, et al. The role of endogenous nitric oxide and platelet-Activating factor in hypoxia-induced intestinal injury in rats. Gastroenterology 1994;106:346-52.
43. Shah P, Shah V. Arginine supplementation for prevention of necrotising enterocolitis in preterm infants. Cochrane Database Syst Rev 2007; CD004339.